FindTrial
Sign In

In-vitro study for sensitivity to Cephalexin in samples from community acquired skin and soft tissue infections

In-Vitro susceptibility of commonly involved pathogens to Cephalexin, isolated from community acquired skin and Soft tissue infections in urban/semi-urban setting in India - CEPH:SSTI-001

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/01/022605
Enrollment
200
Registered
2020-01-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L029- Cutaneous abscess, furuncle and carbuncle, unspecified

Interventions

None listed

Sponsors

CTQuest LLP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Gram positive cultures from community acquired/associated skin and soft tissue infection. A skin and soft tissue infection will be considered community-associated/acquired if the infection arose outside the healthcare setting and there is no history of surgery, hospitalization, catheterization, any other invasive procedure in the previous year, antibiotic usage in the previous two months or MRSA isolation in the past.

Exclusion criteria

Exclusion criteria: samples from-surgical wounds, post instrumentation, diabetic foot infections, human or animal bite infections or from patients with history of hospital stay in last 3 weeks will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Assess the sensitivity to Cephalexin in bacterial community acquired acute skin and soft tissue infectionsTimepoint: Day 1- At time of sample collection—

Secondary

MeasureTime frame
Identify the bacterial profile of community acquired acute skin and soft tissue infectionsTimepoint: Day 1 at time of sample collection—

Countries

India

Contacts

Public ContactDr Ashish Rastogi

Drs. Tribedi and Roy Diagnostic Laboratory

drkokilabanerjee1@gmail.com9163923569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026